Zhu, E., J. Oh, C. Dambkowski, and H. Shaheen. “APG777, a High-Affinity Humanized IgG1 Monoclonal Antibody Targeting IL-13, Demonstrates Prolonged Half-Life in Non-Human Primates”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 1, Jan. 2024, p. s315, doi:10.25251/skin.8.supp.315.